---

Neonatal CPAP: A Complete Teaching Reference for Neonatologists

---

1. WHAT IS nCPAP AND WHY DOES IT WORK?

• Prevents alveolar collapse at end-expiration by maintaining FRC (functional residual capacity)
• Reduces the work of breathing by splinting open the compliant preterm chest wall
• Stabilizes surfactant at the alveolar surface (reduces surface area change and surfactant consumption)
• Improves oxygenation by increasing mean airway pressure and V/Q matching
• Reduces apnoea by maintaining upper airway tone, stimulating breathing via Hering-Breuer reflex, and stabilizing subglottic airway resistance
• Improves thoracoabdominal synchrony, reducing paradoxical breathing in preterm infants

---

2. INDICATIONS FOR nCPAP IN PRETERM INFANTS

Primary (de novo) indications:

Post-extubation (most common use in extreme preterm):

• All infants <30 weeks should be extubated to nCPAP (not room air or low-flow O₂)
• Cochrane review (Ho et al. 2024, PMID 39392114) confirms nCPAP immediately post-extubation reduces re-intubation rates in preterm infants

---

3. CONTRAINDICATIONS

---

4. INITIAL SETTINGS FOR nCPAP

Weaning CPAP:

• Wean FiO₂ first, then CPAP level
• Do NOT wean CPAP below 5 cmH₂O until FiO₂ is 21% for at least 2-5 days
• For GA <25 weeks: maintain CPAP until at least 34 weeks PMA
• For GA <28 weeks: maintain until at least 32 weeks PMA

Criteria to trial off CPAP:

• On CPAP 5 cmH₂O for ≥48 hours
• FiO₂ 21%
• RR <60/min for 24 hours
• No significant work of breathing
• Infrequent apnoea (<2 spells per 12 hours)

---

5. BUBBLE CPAP vs VENTILATOR-DERIVED CPAP

How each works:

Clinical evidence - which is better?

• Bubble CPAP is preferred, particularly for post-extubation support in infants <30 weeks
• The oscillatory component of bubble CPAP is thought to provide a "micro-HFOV" effect - enhancing gas exchange and lung recruitment beyond what simple PEEP provides
• Small RCTs show lower re-intubation rates and fewer days on respiratory support with bubble CPAP vs ventilator CPAP after extubation in very preterm infants
• However, the Polin & Sahni review (PMID 37118971) notes that compared to variable-flow fluidic opposition systems (like Infant Flow Driver/SiPAP), bubble CPAP's advantage is less clear - those systems may be equivalent or superior
• The Gross et al. 2025 review (PMID 41547602) confirms bubble CPAP generates oscillations that vary dynamically with lung mechanics and likely contribute to its physiological benefits

Summary recommendation:

---

6. CPAP FAILURE - WHEN TO ESCALATE TO PPV

Definition of CPAP Failure:

Practical CPAP failure protocol:

1. Check interface - ensure seal, correct prong size, mask fit
2. Check bubbling (bubble CPAP) - circuit disconnection is common
3. Try different interface (switch prongs to mask or vice versa)
4. Reposition infant (prone or semi-prone may help temporarily)
5. Ensure OGT is open and draining
6. Consider chin strap if mouth is open (significant pressure leak)
7. Try increasing CPAP to 8 cmH₂O
8. Consider escalating to NIPPV/BiPAP as a step before intubation

• FiO₂ >0.40-0.50 on CPAP ≥7-8 cmH₂O persisting >30-60 min despite optimisation
• Repeated apnoeas requiring PPV bag mask
• Progressive respiratory/metabolic acidosis
• Haemodynamic compromise
• Immediate post-birth: GA <26 weeks or Silverman-Anderson score consistently high despite initial CPAP

• Give surfactant (INSURE or LISA/MIST technique preferred to minimize invasive ventilation time)
• Extubate back to CPAP/NIPPV as soon as possible (FiO₂ <0.30, MAP <9, rate <20)

---

7. CPAP INTERFACES: NASAL PRONGS vs NASAL MASK vs RAM CANNULA

---

A. SHORT BINASAL PRONGS (e.g., Hudson Prongs, Fisher & Paykel prongs, Argyle prongs)

• Gestational age 24-34 weeks
• Infants on high PEEP (≥7 cmH₂O) where pressure loss must be minimised
• When FiO₂ requirements are high and optimal seal is needed

• BW <700g: size 0 (extra small)
• BW 700-1000g: size 1 (small)
• BW 1000-2000g: size 2 (medium)
• BW >2000g: size 3/4 (large)

---

B. NASAL MASK

• Alternate with prongs every 3-6 hours to reduce nasal trauma (cycling interfaces is best practice)
• Primary choice when nasal trauma is developing or nasal anatomy makes prong sizing difficult
• Larger preterm (>1500g) or near-term infants may tolerate mask better
• Some units prefer mask as primary interface for all CPAP patients (evidence emerging)

---

C. RAM CANNULA (Neotech RAM Cannula)

• Temporary relief during nasal septal breakdown (short period while nose heals)
• Transport setting when simplicity/stability of interface is prioritised over perfect seal
• Near-term or term infants (≥36 weeks) with milder respiratory distress, where some pressure loss is acceptable
• Transitional step between CPAP and HFNC weaning

---

8. BRAND COMPARISON: FISHER & PAYKEL vs DRÄGER

Which is better?

• You anticipate needing to escalate to NIPPV, HFOV, or conventional ventilation on the same device without changing equipment (reduces disturbance to the infant)
• You need very precise PEEP control (e.g., in post-surgical cases)
• Your unit uses synchronised NIPPV (SIPPV/SIMV) as the primary non-invasive mode

---

9. INTERFACE CYCLING - BEST PRACTICE

---

10. QUICK REFERENCE SUMMARY CARD

nCPAP in Preterm - Quick Reference

INITIAL SETTINGS:
  CPAP: 6-7 cmH₂O  |  Flow: 6-8 L/min  |  SpO₂ target: 90-95%
  FiO₂: titrate    |  OGT: open drainage  |  Humidification: 37°C

FAILURE CRITERIA (any one):
  FiO₂ >0.40 on CPAP ≥7  |  PaCO₂ >60, pH <7.25
  Recurrent apnoea needing PPV  |  Worsening WOB despite optimisation

BEFORE INTUBATING - OPTIMISE:
  ✓ Check interface seal  ✓ Check bubbling  ✓ Switch interface
  ✓ OGT open  ✓ Chin strap  ✓ Try CPAP 8  ✓ Consider NIPPV

INTERFACE CHOICE:
  1st: Short binasal prongs (best seal, best evidence)
  2nd: Nasal mask (less trauma, good seal)
  3rd: RAM cannula (comfort/transport only - significant pressure loss)
  Cycle prongs/mask every 3-6h

BUBBLE vs VENTILATOR:
  Bubble CPAP: preferred for primary/post-extubation (oscillations + cost)
  Ventilator: use when NIPPV/HFOV escalation anticipated
  F&P bubble = standard; Dräger = escalation/full ventilation

---

KEY RECENT EVIDENCE (for your slides)

• Mukerji et al. 2025 (Cochrane, PMID 40590276) - 61 RCTs, 7554 preterm infants: NIPPV and NIHFOV reduce treatment failure vs CPAP alone as primary mode. CPAP remains reference standard but consider NIPPV as first-line in higher-risk infants.
• Gross et al. 2025 (PMID 41547602) - Review of bubble CPAP mechanisms: oscillations are dynamic, vary with lung mechanics, and likely contribute to clinical benefit beyond simple PEEP.
• Srivastav et al. 2026 (PMID 42249212) - RCT, 210 preterm <34 weeks: RAM cannula is NOT non-inferior to nasal mask for preventing mechanical ventilation. Nasal mask needed MV in 12%, RAM cannula in 21%. Nasal injury comparable.
• Ho et al. 2024 (Cochrane, PMID 39392114) - nCPAP post-extubation significantly reduces re-intubation in preterm infants vs no support.
• Polin & Sahni 2025 (PMID 37118971) - Physiological review: variable-flow fluidic systems may match bubble CPAP; distinction from ventilator constant-pressure CPAP is well established.

---

---

Latest NICU Guidelines on CPAP Failure Criteria and Escalation to Mechanical Ventilation

---

1. HOW CPAP FAILURE IS DEFINED (Consensus Definition)

---

2. CLINICAL CRITERIA FOR CPAP FAILURE (When to Escalate)

A. Oxygenation Failure

---

B. Ventilatory Failure (Hypercapnia / Acidosis)

---

C. Apnoea

---

D. Clinical Work of Breathing / Severity Scoring

---

E. Other Absolute Indications for Intubation

1. Cardiovascular compromise - myocardial dysfunction, cardiac failure, septic shock
2. Pulmonary hypertension (persistent, requiring iNO)
3. Unresponsive severe bradycardia (HR <100) in delivery room despite PPV
4. Gestational age 22-23+6 weeks - European Consensus 2025 states most require planned intubation at birth; 24+0-24+6 weeks requires clinical judgement
5. Air leak (tension pneumothorax, PIE) requiring drainage under PPV
6. Major upper airway obstruction not manageable with CPAP
7. Requirement for second/third dose surfactant at high FiO₂ (Ashford: consider carefully at FiO₂ ≥0.30 for second dose)

---

3. OPTIMISE BEFORE INTUBATING - THE "RESCUE STEPS"

CPAP FAILURE RESCUE CHECKLIST (before intubating)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
□ Interface seal - prong size correct? 2mm gap from septum?
□ Bubbling maintained (bubble CPAP) - check water level
□ Circuit disconnection / leak
□ Orogastric tube on free drainage - gastric distension?
□ Head position - neutral, not flexed
□ Secretions/nasal obstruction
□ Switch interface (prongs → mask or vice versa)
□ Increase CPAP to 8 cmH₂O (if not already)
□ Chin strap if mouth-breathing
□ Caffeine dose optimised (if apnoea)
□ Blood transfusion (if anaemia contributing)
□ Antibiotics (if sepsis suspected)

---

4. THE ESCALATION LADDER (Step-by-Step)

ESCALATION LADDER

Step 1: nCPAP
  CPAP 5-8 cmH₂O + optimise (see checklist above)
  ↓ (if failing on Step 1)

Step 2: Escalate within Non-Invasive Support
  A. Consider LISA/MIST surfactant (if FiO₂ ≥0.30, RDS)
     - Can avoid intubation in 50-60% of cases
  B. Switch to NIPPV / BiPAP / DuoPAP
     - PEEP 6-8 cmH₂O, PIP set 2-3 cmH₂O higher
     - European Consensus 2025: NIPPV superior to CPAP
       post-extubation (RR 0.78 for reintubation)
  C. Consider NIHFOV (nasal HFOV) if available
     - Cochrane 2025: reduces intubation vs CPAP (nRR 0.48)
  ↓ (if failing on Step 2)

Step 3: Invasive Mechanical Ventilation
  - Volume-targeted ventilation preferred (VTV)
  - Intubate → give surfactant immediately
  - Lung protective strategy: VT 4-5 mL/kg, PEEP 4-6
  - Target early extubation back to NIPPV/CPAP
  ↓ (if failing on conventional MV)

Step 4: High-Frequency Oscillatory Ventilation (HFOV)
  - MAP >12, PIP >32, failure to achieve TV on maximal PIP
  - Hypoxic respiratory failure despite adequate conventional MV
  - Significant respiratory acidosis refractory to conventional MV

---

5. SURFACTANT AS A BRIDGE (Avoiding CPAP Failure)

---

6. PREDICTORS OF CPAP FAILURE - EARLY IDENTIFICATION TOOLS

---

7. POST-INTUBATION: BACK TO CPAP/NIV AS SOON AS POSSIBLE

---

8. SUMMARY TABLE - CPAP FAILURE CRITERIA BY GUIDELINE (2024-2026)

---

KEY RECENT CITATIONS FOR YOUR SLIDES

---

---

PEEP Level in Defining CPAP Failure - Evidence and Current Practice

The Core Concept: PEEP as the "Denominator" of CPAP Failure

CPAP failure = FiO₂ >X% persisting despite CPAP at maximum PEEP (typically ≥7-8 cmH₂O)

---

1. What PEEP Level Defines "Maximum CPAP"?

Across Major Trials and Guidelines:

---

2. Evidence on Optimal Starting PEEP and Titration

The critical honest statement from current literature:

"No clinical studies specifically assessed the effect of different PEEP levels during the active phase of RDS in preterm infants on outcomes such as the need for invasive mechanical ventilation."

• OPTTIMMAL Trial Protocol, Waitz et al., Trials 2020

Evidence by PEEP range:

---

3. The OPTTIMMAL Trial - The Key Direct Evidence on PEEP Level

• Population: 216 preterm infants, 26+0 to 29+6 weeks
• High PEEP group: 6-8 cmH₂O (titrated by FiO₂)
• Low PEEP group: 3-5 cmH₂O (titrated by FiO₂)
• Primary outcome: Intubation >1h OR FiO₂ >0.5 for >1h OR pCO₂ ≥70 mmHg on two consecutive ABGs ≥2h apart
• Hypothesis: Higher PEEP reduces CPAP failure

---

4. Specific PEEP-Based Failure Thresholds Used in Research Studies

---

5. Post-Extubation CPAP: Higher PEEP Has Direct Evidence

• StatPearls 2026 (citing original research): PEEP 9-11 cmH₂O post-extubation is more effective than standard PEEP 5-7 cmH₂O in preventing extubation failure in extremely preterm neonates
• The physiological basis: chronic lung disease/BPD lungs have worse compliance and increased airway resistance; a higher distending pressure is needed to maintain FRC and prevent atelectasis
• Clinical implication: When extubating an extremely preterm infant (<28 weeks, especially if post-BPD), start CPAP at 7-8 cmH₂O rather than 5-6 cmH₂O, and do not wean PEEP until FiO₂ is stable at 21%

---

6. Practical Framework: PEEP Titration Before Declaring Failure

PEEP TITRATION ALGORITHM BEFORE DECLARING CPAP FAILURE
═══════════════════════════════════════════════════════

Start: CPAP 5-6 cmH₂O
        ↓
FiO₂ rising or WOB worsening?
        ↓
Increase PEEP to 7 cmH₂O
        ↓
Still failing (FiO₂ >0.40, pCO₂ >55, WOB persisting)?
        ↓
Increase PEEP to 8 cmH₂O
Consider LISA/surfactant NOW if FiO₂ ≥0.30 (European 2025)
        ↓
Still failing on PEEP 8 cmH₂O + FiO₂ >0.40-0.50?
        ↓
→ CPAP FAILURE DECLARED
→ Step 1: Escalate to NIPPV/BiPAP (PIP 2-3 cmH₂O > PEEP, same PEEP)
→ Step 2: LISA if not yet done
→ Step 3: Intubate + surfactant + MV

⚠️ PEEP >8 cmH₂O: watch for pneumothorax
⚠️ COIN trial: CPAP 8 cmH₂O associated with higher
   pneumothorax rate (9% vs 3%), though confounded
   by lower surfactant use

---

7. Summary: What We Know vs What We Don't

---

pH and PaCO₂ as Criteria for CPAP Failure - The Evidence

The Core Problem: No Consensus, No RCT Specifically Testing These Thresholds

There is no RCT that has specifically studied which pH/PaCO₂ threshold is the correct trigger to intubate a preterm infant on CPAP. The thresholds used across studies were chosen empirically, varied widely, and were secondary criteria within trials designed to answer different questions.

---

1. What the Major Trials Used - Trial-by-Trial Breakdown

SUPPORT Trial (Finer et al., NEJM 2010) - The Landmark Trial

• Population: 1316 infants, 24-27+6 weeks
• pH/PaCO₂ failure criterion:

  PaCO₂ >65 mmHg documented by a single blood gas measurement within 1 hour before intubation (No pH threshold specified as a standalone criterion - hypercapnia alone triggered intubation)

• Other criteria: FiO₂ >0.50 for 1 hour, haemodynamic instability
• Notable: The SUPPORT trial did not pair the CO₂ threshold with a pH floor - any PaCO₂ >65 triggered intubation regardless of whether pH was acceptable

---

COIN Trial (Morley et al., NEJM 2008)

• Population: 610 infants, 25-28+6 weeks; started CPAP 8 cmH₂O at 5 min of life
• pH/PaCO₂ failure criterion:

  PaCO₂ >8-8.5 kPa (= 60-64 mmHg) with H⁺ >65 nmol/L (= pH <7.19)

• Other criteria: FiO₂ >0.60, apnoea requiring intubation
• Notable: COIN used a combined threshold - both PaCO₂ elevation AND acidosis had to be present. This is a more conservative trigger (tolerates high CO₂ if pH is still acceptable).
• Key insight from GGC analysis: By showing no difference in BPD/death between CPAP and intubation groups, COIN implies that PaCO₂ in the 8-8.5 kPa range with pH still ≥7.19 may be safe - i.e., you don't need to intubate for CO₂ alone if the pH is holding.

---

CURPAP Trial (Sandri et al., Pediatrics 2010)

• Population: 208 infants, 25-28+6 weeks
• pH/PaCO₂ failure criterion:

  PaCO₂ >65 mmHg with pH <7.22

• Combined with FiO₂ >0.40-0.50 and recurrent apnoea

---

VON Delivery Room Management Trial (Dunn et al.)

• pH/PaCO₂ failure criterion:

  PaCO₂ >60-65 mmHg with pH <7.22

---

Randomised Trial of Bubble CPAP (Rojas et al., J Pediatrics, Colombia)

• pH/PaCO₂ failure criterion:

  PaCO₂ >60 mmHg with pH <7.20 on two consecutive ABGs within 30 minutes

• This is the most stringent definition - requiring persistence on repeat ABG before acting

---

Hopkins Medicine Clinical Pathway (2023)

• pH/PaCO₂ failure criterion:

  PaCO₂ >60 mmHg AND pH <7.20, confirmed on 2 consecutive blood gases 30-60 minutes apart

• Explicit time-based confirmation requirement before declaring failure

---

2. Summary Table: pH and PaCO₂ Thresholds Across Evidence Sources

---

3. The Key Conceptual Distinction: PaCO₂ Alone vs Combined pH+PaCO₂

Should you intubate for high PaCO₂ alone, even if pH is acceptable?

Avoid PaCO₂ >60 mmHg in the first 72 hours of life due to the risk of cerebral vasodilation and intraventricular haemorrhage (IVH).

---

4. Permissive Hypercapnia: Does It Help in Preterm Infants?

• Permissive hypercapnia vs normocapnia in ventilated preterm infants
• No significant difference in BPD (RR 0.94, 95% CI 0.74-1.18)
• No significant difference in death or BPD (RR 1.05, 95% CI 0.90-1.23)
• Possible signal for increased NEC with permissive hypercapnia (RR 1.69, CI 0.98-2.91) - not significant but concerning
• All evidence graded as very low certainty
• Bottom line: Permissive hypercapnia doesn't help, but also doesn't clearly harm - except possibly for NEC

---

5. Why Queensland Health Uses pH <7.30 (More Conservative Than Trials)

• A "signal to act early" philosophy rather than a hard failure threshold
• The intent is to escalate (check, optimise, consider surfactant) before frank failure, not necessarily to intubate immediately at pH 7.29
• It aligns with the European 2025 approach of proactive surfactant via LISA before overt decompensation

---

6. The "Two ABG Rule" - Important Practical Detail

• Rojas: 2 ABGs within 30 minutes
• Hopkins: 2 ABGs 30-60 min apart
• OPTTIMMAL: 2 ABGs ≥2 hours apart

---

7. Practical Framework for pH/PaCO₂-Based Decision Making

CLINICAL DECISION TREE: pH / PaCO₂ on CPAP
════════════════════════════════════════════

ABG result on CPAP:

PaCO₂ 45-55 mmHg, pH >7.30
→ Normal/acceptable. Continue CPAP. Monitor.

PaCO₂ 55-60 mmHg, pH 7.25-7.30
→ CAUTION - "Respiratory acidosis signal"
→ Optimise CPAP (PEEP, interface, OGT)
→ Consider surfactant via LISA if FiO₂ ≥0.30
→ Repeat ABG in 30-60 min
→ Consider escalation to NIPPV
→ If first 72h of life: lower threshold to act (IVH risk)

PaCO₂ 60-65 mmHg, pH 7.20-7.25
→ SIGNIFICANT FAILURE SIGNAL
→ Repeat ABG in 30-60 min after optimisation
→ If confirmed: CPAP failure on most trial criteria
→ Escalate to NIPPV first; if already on NIPPV → intubate
→ Give surfactant (LISA or intubation + surfactant)

PaCO₂ >65 mmHg, pH <7.20 (×2 ABGs)
→ CPAP/NIV FAILURE - INTUBATE
→ Universal threshold across all major trials
→ No delay in management

PaCO₂ >70 mmHg (any pH)
→ INTUBATE (OPTTIMMAL protocol threshold)
→ Likely ventilatory failure regardless of pH compensation

⚠️ SPECIAL RULE - First 72h of life:
   PaCO₂ persistently >60 mmHg = act earlier
   IVH risk from cerebral vasodilation is highest
   in first 3 days; don't wait for pH to drop

---

8. Summary of Evidence Strength

---